Ionic Liquid-Controlled Shape Transformation of Spherical to Nonspherical Polymersomes via Hierarchical Self-Assembly of a Diblock Copolymer

Pulmonary inhalation for disease treatment: Basic research and clinical translations

Pulmonary drug delivery has the advantages of being rapid, efficient, and well-targeted, with few systemic side effects. In addition, it is non-invasive and has good patient compliance, making it a highly promising drug delivery mode. However, there have been limited studies on drug delivery via pulmonary inhalation compared with oral and intravenous modes. This paper summarizes the basic research and clinical translation of pulmonary inhalation drug delivery for the treatment of diseases and provides insights into the latest advances in pulmonary drug delivery. The paper discusses the processing methods for pulmonary drug delivery, drug carriers (with a focus on various types of nanoparticles), delivery devices, and applications in pulmonary diseases and treatment of systemic diseases (e.g., COVID-19, inhaled vaccines, diagnosis of the diseases, and diabetes mellitus) with an updated summary of recent research advances. Furthermore, this paper describes the applications and recent progress in pulmonary drug delivery for lung diseases and expands the use of pulmonary drugs for other systemic diseases.

Biodegradable Microrobots and Their Biomedical Applications: A Review

During recent years, microrobots have drawn extensive attention owing to their good controllability and great potential in biomedicine. Powered by external physical fields or chemical reactions, these untethered microdevices are promising candidates for in vivo complex tasks, such as targeted delivery, imaging and sensing, tissue engineering, hyperthermia, and assisted fertilization, among others. However, in clinical use, the biodegradability of microrobots is significant for avoiding toxic residue in the human body. The selection of biodegradable materials and the corresponding in vivo environment needed for degradation are increasingly receiving attention in this regard. This review aims at analyzing different types of biodegradable microrobots by critically discussing their advantages and limitations. The chemical degradation mechanisms behind biodegradable microrobots and their typical applications are also thoroughly investigated. Furthermore, we examine their feasibility and deal with the in vivo suitability of different biodegradable microrobots in terms of their degradation mechanisms; pathological environments; and corresponding biomedical applications, especially targeted delivery. Ultimately, we highlight the prevailing obstacles and perspective solutions, ranging from their manufacturing methods, control of movement, and degradation rate to insufficient and limited in vivo tests, that could be of benefit to forthcoming clinical applications.

Aqueous, Mixed Micelles as a Means of Delivering the Hydrophobic Ionic Liquid EMIM TFSI to Graphene Oxide Surfaces

Most ionic liquids (ILs) are not surface-active and cannot, alone, be directed to assemble at surfaces─despite their potential as nonvolatile structure-directing agents and use as advanced materials in a multitude of applications. In this work, we investigate aqueous systems of common nonionic surfactants (Triton X-100 and Tween 20), which we use to solubilize 1-ethyl-3-methylimidazolium bis(trifluoromethylsulfonyl)imide. The resulting solution of mixed micelle leads to spontaneous adsorption of the IL/surfactant complex onto graphene oxide (GO) surfaces, forming a compact film. Adsorption isotherms generated by fluorescence labeling of the IL and surfactant phases are used to quantify the extent of adsorption. While sensitive to the GO dispersion concentration, upwards of 3 g IL/g GO adsorb under dilute conditions. Atomic force microscopy is used to show that the adsorbed layer uniformly distributes as an ∼1 nm thick coating (per GO side) as the system reaches the first plateau of a Langmuir-type isotherm. Adsorption beyond this plateau is possible but leads to thicker (>30 nm), inhomogeneous adsorbed layers. Both micellar size in solution and adsorbed layer thickness reduce upon the addition of IL to the surfactant phase, suggesting significant interactions among the materials and nonideal mixing of the components.